Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The ligand for CD137 (CD137L; also called 4-1BBL) is mainly expressed on activated APCs such as dendritic cells, B cells and macrophages. Even though CD137L functions as a trigger of the CD137 signaling pathway for T cell activation and expansion, engagement of CD137L can deliver a signal leading to the production of proinflammatory cytokines in macrophages. Methods: We generated cell-permeable TAT-CD137L cytoplasmic domain fusion protein (TAT-CD137Lct) and examined its ability to initiate the CD137L reverse signaling pathway. Results: Treatment of TAT-CD137Lct induced the production of high levels of IL-6 and TNF-α mRNAs and proteins in peritoneal macrophages. TAT-CD137Lct increased phosphorylation of Erk, p38 MAPK and Jnk, and activated transcription factors C/EBP and CREB. However, TAT-CD137Lct did not visibly affect the degradation of the inhibitor of NF-kB (IkBα). We further demonstrated that JNK activation was required for TAT-CD137Lct-induced production of TNF-α, while activation of Erk and p38 MAPK were involved in IL-6 and TNF-α production. Conclusion: Our results suggest that TAT- CD137Lct is an effective activator for the CD137L reverse signaling pathway.
Abstract
Background: The ligand for CD137 (CD137L; also called 4-1BBL) is mainly expressed on activated APCs such as dendritic cells, B cells and macrophages. Even though CD137L functions as a trigger of the CD137 signaling pathway for T cell activation and expansion, engagement of CD137L can deliver a signal leading to the production of proinflammatory cytokines in macrophages. Methods: We generated cell-permeable TAT-CD137L cytoplasmic domain fusion protein (TAT-CD137Lct) and examined its ability to initiate the CD137L reverse signaling pathway. Results: Treatment of TAT-CD137Lct induced the production of high levels of IL-6 and TNF-α mRNAs and proteins in peritoneal macrophages. TAT-CD137Lct increased phosphorylation of Erk, p38 MAPK and Jnk, and activated transcription factors C/EBP and CREB. However, TAT-CD137Lct did not visibly affect the degradation of the inhibitor of NF-kB (IkBα). We further demonstrated that JNK activation was required for TAT-CD137Lct-induced production of TNF-α, while activation of Erk and p38 MAPK were involved in IL-6 and TNF-α production. Conclusion: Our results suggest that TAT- CD137Lct is an effective activator for the CD137L reverse signaling pathway.
참고문헌 (26)
- Eissner G, "Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system", Cytokine Growth Factor Rev, 15, pp.353~366 (2004)
- Schwarz H, "Biological activities of reverse signal transduction through CD137 ligand", J Leukoc Biol, 77, pp.281~286 (2005)
- Shao Z, "CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction", J Leukoc Biol, 89, pp.21~29 (2011)
- Langstein J, "CD137 (ILA", 4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling, 1998, pp.160, 2488~2494
- Langstein J, "CD137 induces proliferation and endomitosis in monocytes", Blood, 94, pp.3161~3168 (1999)
- Langstein J, "Identification of CD137 as a potent monocyte survival factor", J Leukoc Biol, 65, pp.829~833 (1999)
- Langstein J, "Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation", Biochem Biophys Res Commun, 273, pp.117~122 (2000)
- Ju SW, "A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL", Hybrid Hybridomics, 22, pp.333~338 (2003)
- Laderach D, "4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12", Cell Immunol, 226, pp.37~44 (2003)
- Lippert U, "CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response", Eur J Immunol, 38, pp.1024~1032 (2008)
- Schwarz H, "ILA, a member of the human nerve growth factor", tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival, 1996, pp.87, 2839~2845
- Kwajah MMS, "Biphasic activity of CD137 ligand-stimulated monocytes on T cell apoptosis and proliferation", J Leukoc Biol, 89, pp.707~720 (2011)
- Pauly S, "CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers", J Leukoc Biol, 72, pp.35~42 (2002)
- Pollok KE, "4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells", Eur J Immunol, 24, pp.367~374 (1994)
- Jeon HJ, "CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice", CIRCULATION, 121(9), pp.1124~126, LIPPINCOTT WILLIAMS WILKINS
- Salih HR, "Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells", J Immunol, 165, pp.2903~2910 (2000)
- Gullo C, "Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling", PLoS One, 5, pp.e10845~ (2010)
- Drenkard D, "CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity", FASEB J, 21, pp.456~463 (2007)
- Kang YJ, "Cell surface 4-1BBL mediates sequential signaling pathways ‘downstream' of TLR and is required for sustained TNF production in macrophages", Nat Immunol, 8, pp.601~609 (2007)
- Lee SW, "Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells", Nat Immunol, 9, pp.917~926 (2008)
- Jiang D, "CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages", J Immunol, 181, pp.3923~3932 (2008)
- Jiang D, "Induction of proliferation and monocytic differentiation of human CD34+cells by CD137 ligand signaling", Stem Cells, 26, pp.2372~2381 (2008)
- Asoh S, "PTD-mediated delivery of anti-cell death proteins", peptides and therapeutic enzymes, 2008, pp.60, 499~516
- Choi JM, "Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation", Nat Med, 12, pp.574~579 (2006)
- Choi JM, "Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(50), pp.19875~19880, National Academy of Sciences
- 권병석, "CD137-CD137 Ligand Interactions in Inflammation", Immune Network, 9(3), pp.84~89 (2009), 대한면역학회